speb/financial-data huggingface dataset:
INFQ cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 948000.00
INFQ cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 948000.00
INFQ income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 216471927.00
INFQ income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.26
INFQ income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -30263000.00
INFQ income_statement (quarterly, 2026-03-31) — EBIT: -33575000.00
INFQ income_statement (quarterly, 2026-03-31) — EBITDA: -32627000.00
INFQ cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: 48000.00
INFQ cash_flow (quarterly, 2026-03-31) — End Cash Position: 84874000.00
INFQ cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 525156000.00
INFQ balance_sheet (quarterly, 2026-03-31) — Finished Goods: 245000.00
INFQ cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -19471000.00
INFQ balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -75000.00
INFQ income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 26320000.00
INFQ balance_sheet (quarterly, 2026-03-31) — Goodwill: 9315000.00
INFQ balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 9315000.00
INFQ balance_sheet (quarterly, 2026-03-31) — Gross PPE: 24229000.00
INFQ income_statement (quarterly, 2026-03-31) — Gross Profit: 1991000.00
INFQ income_statement (quarterly, 2026-03-31) — Interest Income: 3202000.00
INFQ income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 3202000.00
INFQ balance_sheet (quarterly, 2026-03-31) — Inventory: 4869000.00
INFQ balance_sheet (quarterly, 2026-03-31) — Invested Capital: 585255000.00
INFQ cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -433065000.00
INFQ balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 125117000.00
INFQ balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 125117000.00
INFQ balance_sheet (quarterly, 2026-03-31) — Leases: 1428000.00
INFQ balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 3805000.00
INFQ balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 3805000.00
INFQ balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 17599000.00
INFQ income_statement (quarterly, 2026-03-31) — Net Income: -30263000.00
INFQ income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -30263000.00
INFQ income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -30263000.00
INFQ income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -30263000.00
INFQ income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -30263000.00
INFQ cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -30263000.00
INFQ income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -30263000.00
INFQ income_statement (quarterly, 2026-03-31) — Net Interest Income: 3202000.00
INFQ cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -432753000.00
INFQ income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 3202000.00
INFQ cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: 524385000.00
INFQ balance_sheet (quarterly, 2026-03-31) — Net PPE: 12725000.00
INFQ cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -312000.00
INFQ balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 575940000.00
INFQ income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -32627000.00
INFQ income_statement (quarterly, 2026-03-31) — Normalized Income: -30263000.00
INFQ cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -19159000.00
INFQ income_statement (quarterly, 2026-03-31) — Operating Income: -33575000.00
INFQ income_statement (quarterly, 2026-03-31) — Operating Revenue: 9461000.00
INFQ balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 216471927.00
INFQ balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 38000.00
INFQ balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -75000.00
INFQ income_statement (quarterly, 2026-03-31) — Other Gand A: 26320000.00
INFQ income_statement (quarterly, 2026-03-31) — Other Income Expense: 110000.00
INFQ cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -111000.00
INFQ balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 578000.00
INFQ income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 110000.00
INFQ income_statement (quarterly, 2026-03-31) — Other Operating Expenses: -705000.00
INFQ balance_sheet (quarterly, 2026-03-31) — Other Properties: 5202000.00
INFQ balance_sheet (quarterly, 2026-03-31) — Other Receivables: 5675000.00
INFQ balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 358866000.00
INFQ balance_sheet (quarterly, 2026-03-31) — Payables: 3718000.00
INFQ balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 13521000.00
INFQ balance_sheet (quarterly, 2026-03-31) — Preferred Securities Outside Stock Equity: 0.00
INFQ balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
INFQ balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 3807000.00
INFQ income_statement (quarterly, 2026-03-31) — Pretax Income: -30263000.00
INFQ cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 771000.00
INFQ balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
INFQ cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -444153000.00
INFQ cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -312000.00
INFQ balance_sheet (quarterly, 2026-03-31) — Raw Materials: 2376000.00
INFQ balance_sheet (quarterly, 2026-03-31) — Receivables: 12533000.00
INFQ income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 7470000.00
INFQ income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 948000.00
INFQ income_statement (quarterly, 2026-03-31) — Research And Development: 9951000.00
INFQ balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -261349000.00
INFQ cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 11400000.00
INFQ income_statement (quarterly, 2026-03-31) — Selling General And Administration: 26320000.00
INFQ balance_sheet (quarterly, 2026-03-31) — Share Issued: 216471927.00
INFQ cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 8293000.00
INFQ balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 585255000.00
INFQ balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 575940000.00
INFQ income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
INFQ income_statement (quarterly, 2026-03-31) — Tax Provision: 0.00
INFQ income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.00
INFQ balance_sheet (quarterly, 2026-03-31) — Total Assets: 612611000.00
INFQ balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 585255000.00
INFQ balance_sheet (quarterly, 2026-03-31) — Total Debt: 4893000.00
INFQ balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 585255000.00
INFQ income_statement (quarterly, 2026-03-31) — Total Expenses: 43036000.00
INFQ balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 27356000.00
INFQ balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 147735000.00
INFQ balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 3805000.00
INFQ income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -33575000.00
INFQ balance_sheet (quarterly, 2026-03-31) — Work In Process: 2248000.00
INFQ balance_sheet (quarterly, 2026-03-31) — Working Capital: 441325000.00
INFU balance_sheet (annual, 2021-12-31) — Current Debt: 349000.00
INFU balance_sheet (annual, 2021-12-31) — Current Debt And Capital Lease Obligation: 349000.00
INFU cash_flow (annual, 2021-12-31) — Net Other Financing Charges: -386000.00
INFU balance_sheet (annual, 2021-12-31) — Other Current Borrowings: 349000.00
INFU income_statement (annual, 2021-12-31) — Provision For Doubtful Accounts: 77000.00
INFU income_statement (annual, 2022-12-31) — +Operating Expense: 58906000.00
INFU income_statement (annual, 2022-12-31) — +Total Revenue: 109914000.00
INFU balance_sheet (annual, 2022-12-31) — Accounts Payable: 8341000.00
INFU balance_sheet (annual, 2022-12-31) — Accounts Receivable: 16871000.00
INFU balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -62353000.00
INFU balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 105856000.00
INFU balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -1100000.00
INFU income_statement (annual, 2022-12-31) — Amortization: 2494000.00
INFU cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 2494000.00
INFU cash_flow (annual, 2022-12-31) — Amortization Of Intangibles: 2494000.00
INFU income_statement (annual, 2022-12-31) — Amortization Of Intangibles Income Statement: 2494000.00
INFU income_statement (annual, 2022-12-31) — Basic Average Shares: 20648818.00
INFU income_statement (annual, 2022-12-31) — Basic EPS: 0.00
INFU cash_flow (annual, 2022-12-31) — Beginning Cash Position: 186000.00
INFU cash_flow (annual, 2022-12-31) — Capital Expenditure: -15076000.00
INFU balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 3761000.00
INFU balance_sheet (annual, 2022-12-31) — Capital Stock: 2000.00
INFU balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 165000.00
INFU balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 165000.00
INFU cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -6060000.00
INFU cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -11478000.00
INFU cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 17517000.00
INFU cash_flow (annual, 2022-12-31) — Change In Account Payable: 2942000.00
INFU cash_flow (annual, 2022-12-31) — Change In Inventory: -882000.00
INFU cash_flow (annual, 2022-12-31) — Change In Other Current Assets: -522000.00
INFU cash_flow (annual, 2022-12-31) — Change In Payable: 2942000.00
INFU cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 2942000.00
INFU cash_flow (annual, 2022-12-31) — Change In Receivables: -1153000.00
INFU cash_flow (annual, 2022-12-31) — Change In Working Capital: 385000.00
INFU cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -1153000.00
INFU cash_flow (annual, 2022-12-31) — Changes In Cash: -21000.00
INFU balance_sheet (annual, 2022-12-31) — Common Stock: 2000.00
INFU balance_sheet (annual, 2022-12-31) — Common Stock Equity: 48003000.00
INFU cash_flow (annual, 2022-12-31) — Common Stock Payments: -6652000.00
INFU income_statement (annual, 2022-12-31) — Cost Of Revenue: 49354000.00
INFU balance_sheet (annual, 2022-12-31) — Current Assets: 24779000.00
INFU balance_sheet (annual, 2022-12-31) — Current Liabilities: 14467000.00
INFU cash_flow (annual, 2022-12-31) — Deferred Income Tax: 19000.00
INFU cash_flow (annual, 2022-12-31) — Deferred Tax: 19000.00
INFU cash_flow (annual, 2022-12-31) — Depreciation: 10866000.00
INFU cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 13360000.00
INFU income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 2494000.00
INFU cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 13360000.00
INFU income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 2494000.00
INFU income_statement (annual, 2022-12-31) — Diluted Average Shares: 21547306.00
INFU income_statement (annual, 2022-12-31) — Diluted EPS: 0.00
INFU income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 18000.00
INFU income_statement (annual, 2022-12-31) — EBIT: 1532000.00
INFU income_statement (annual, 2022-12-31) — EBITDA: 14892000.00
INFU cash_flow (annual, 2022-12-31) — End Cash Position: 165000.00
INFU balance_sheet (annual, 2022-12-31) — Financial Assets: 1965000.00
INFU cash_flow (annual, 2022-12-31) — Financing Cash Flow: -6060000.00
INFU cash_flow (annual, 2022-12-31) — Free Cash Flow: 2441000.00
INFU cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: -250000.00
INFU balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: 1489000.00
INFU income_statement (annual, 2022-12-31) — General And Administrative Expense: 44153000.00
INFU balance_sheet (annual, 2022-12-31) — Goodwill: 3710000.00
INFU balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 12146000.00
INFU balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 17971000.00
INFU balance_sheet (annual, 2022-12-31) — Gross PPE: 110356000.00
INFU income_statement (annual, 2022-12-31) — Gross Profit: 60560000.00
INFU cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 153000.00
INFU income_statement (annual, 2022-12-31) — Interest Expense: 1402000.00
INFU income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 1402000.00
INFU cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 1310000.00
INFU balance_sheet (annual, 2022-12-31) — Inventory: 4821000.00
INFU balance_sheet (annual, 2022-12-31) — Invested Capital: 81160000.00
INFU cash_flow (annual, 2022-12-31) — Investing Cash Flow: -11478000.00
INFU cash_flow (annual, 2022-12-31) — Issuance Of Debt: 42022000.00
INFU balance_sheet (annual, 2022-12-31) — Leases: 3498000.00
INFU balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 3761000.00
INFU balance_sheet (annual, 2022-12-31) — Long Term Debt: 33157000.00
INFU balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 36918000.00
INFU cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 42022000.00
INFU cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -42035000.00
INFU balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 5797000.00
INFU cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: 0.00
INFU cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -6652000.00
INFU balance_sheet (annual, 2022-12-31) — Net Debt: 32992000.00
INFU income_statement (annual, 2022-12-31) — Net Income: 18000.00
INFU income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 18000.00
INFU income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 18000.00
INFU income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 18000.00
INFU income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 18000.00
INFU cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 18000.00
INFU income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 18000.00
INFU income_statement (annual, 2022-12-31) — Net Interest Income: -1402000.00
INFU cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -13000.00
INFU cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -13000.00
INFU income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -1402000.00
INFU cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -750000.00
INFU balance_sheet (annual, 2022-12-31) — Net PPE: 48003000.00
INFU cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -11478000.00
INFU balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 35857000.00
INFU balance_sheet (annual, 2022-12-31) — Non Current Deferred Assets: 9625000.00
INFU balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 9625000.00
INFU income_statement (annual, 2022-12-31) — Normalized EBITDA: 14892000.00
INFU income_statement (annual, 2022-12-31) — Normalized Income: 18000.00
INFU cash_flow (annual, 2022-12-31) — Operating Cash Flow: 17517000.00
INFU cash_flow (annual, 2022-12-31) — Operating Gains Losses: -250000.00
INFU income_statement (annual, 2022-12-31) — Operating Income: 1654000.00
INFU income_statement (annual, 2022-12-31) — Operating Revenue: 109914000.00
INFU balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 20781977.00
INFU balance_sheet (annual, 2022-12-31) — Other Current Assets: 2922000.00
INFU balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 6126000.00
INFU balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: 1489000.00
INFU income_statement (annual, 2022-12-31) — Other Gand A: 44153000.00
INFU income_statement (annual, 2022-12-31) — Other Income Expense: -122000.00
INFU balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 8436000.00
INFU cash_flow (annual, 2022-12-31) — Other Non Cash Items: 73000.00
INFU balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 2870000.00
INFU income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: -122000.00
INFU balance_sheet (annual, 2022-12-31) — Other Properties: 101061000.00
INFU balance_sheet (annual, 2022-12-31) — Payables: 8341000.00
INFU balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 8341000.00
INFU balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
INFU income_statement (annual, 2022-12-31) — Pretax Income: 130000.00
INFU cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 1355000.00
INFU balance_sheet (annual, 2022-12-31) — Properties: 0.00
INFU income_statement (annual, 2022-12-31) — Provision For Doubtful Accounts: 87000.00
INFU cash_flow (annual, 2022-12-31) — Provisionand Write Offof Assets: 87000.00
INFU cash_flow (annual, 2022-12-31) — Purchase Of Business: 0.00
INFU cash_flow (annual, 2022-12-31) — Purchase Of PPE: -15076000.00
INFU balance_sheet (annual, 2022-12-31) — Receivables: 16871000.00
INFU income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 38488000.00
INFU income_statement (annual, 2022-12-31) — Reconciled Depreciation: 13360000.00
INFU cash_flow (annual, 2022-12-31) — Repayment Of Debt: -42035000.00
INFU cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -6652000.00
INFU balance_sheet (annual, 2022-12-31) — Retained Earnings: -59344000.00
INFU cash_flow (annual, 2022-12-31) — Sale Of PPE: 3598000.00
INFU income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 12259000.00
INFU income_statement (annual, 2022-12-31) — Selling General And Administration: 56412000.00
INFU balance_sheet (annual, 2022-12-31) — Share Issued: 20781977.00
INFU cash_flow (annual, 2022-12-31) — Stock Based Compensation: 3825000.00
INFU balance_sheet (annual, 2022-12-31) — Stockholders Equity: 48003000.00
INFU balance_sheet (annual, 2022-12-31) — Tangible Book Value: 35857000.00
INFU income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
INFU income_statement (annual, 2022-12-31) — Tax Provision: 112000.00
INFU income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.21
INFU balance_sheet (annual, 2022-12-31) — Total Assets: 99388000.00
INFU balance_sheet (annual, 2022-12-31) — Total Capitalization: 81160000.00
INFU balance_sheet (annual, 2022-12-31) — Total Debt: 36918000.00
INFU balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 48003000.00
INFU income_statement (annual, 2022-12-31) — Total Expenses: 108260000.00
INFU balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 51385000.00
INFU balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 74609000.00
INFU balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 36918000.00
INFU income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 1654000.00
INFU balance_sheet (annual, 2022-12-31) — Working Capital: 10312000.00
INFU income_statement (annual, 2023-12-31) — +Operating Expense: 59021000.00
INFU income_statement (annual, 2023-12-31) — +Total Revenue: 125785000.00
INFU balance_sheet (annual, 2023-12-31) — Accounts Payable: 8009000.00
INFU balance_sheet (annual, 2023-12-31) — Accounts Receivable: 19830000.00
INFU balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -65191000.00
INFU balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 109837000.00
INFU balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -600000.00
INFU income_statement (annual, 2023-12-31) — Amortization: 990000.00
INFU cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 990000.00
INFU cash_flow (annual, 2023-12-31) — Amortization Of Intangibles: 990000.00
INFU income_statement (annual, 2023-12-31) — Amortization Of Intangibles Income Statement: 990000.00
INFU income_statement (annual, 2023-12-31) — Basic Average Shares: 21024382.00
INFU income_statement (annual, 2023-12-31) — Basic EPS: 0.04
INFU cash_flow (annual, 2023-12-31) — Beginning Cash Position: 165000.00
INFU cash_flow (annual, 2023-12-31) — Capital Expenditure: -11117000.00
INFU balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 5799000.00
INFU balance_sheet (annual, 2023-12-31) — Capital Stock: 2000.00
INFU balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 231000.00
INFU balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 231000.00
INFU cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -4423000.00
INFU cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -6734000.00
INFU cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 11223000.00
INFU cash_flow (annual, 2023-12-31) — Change In Account Payable: 2415000.00
INFU cash_flow (annual, 2023-12-31) — Change In Inventory: -1581000.00
INFU cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -4033000.00
INFU cash_flow (annual, 2023-12-31) — Change In Payable: 2415000.00
INFU cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 2415000.00
INFU cash_flow (annual, 2023-12-31) — Change In Receivables: -2363000.00
INFU cash_flow (annual, 2023-12-31) — Change In Working Capital: -5562000.00
INFU cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -2363000.00
INFU cash_flow (annual, 2023-12-31) — Changes In Cash: 66000.00
INFU balance_sheet (annual, 2023-12-31) — Common Stock: 2000.00
INFU balance_sheet (annual, 2023-12-31) — Common Stock Equity: 52302000.00
INFU cash_flow (annual, 2023-12-31) — Common Stock Payments: -1311000.00
INFU income_statement (annual, 2023-12-31) — Cost Of Revenue: 62676000.00
INFU balance_sheet (annual, 2023-12-31) — Current Assets: 30620000.00
INFU balance_sheet (annual, 2023-12-31) — Current Liabilities: 15713000.00
INFU cash_flow (annual, 2023-12-31) — Deferred Income Tax: 633000.00
INFU cash_flow (annual, 2023-12-31) — Deferred Tax: 633000.00
INFU cash_flow (annual, 2023-12-31) — Depreciation: 11518000.00
INFU cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 12508000.00
INFU income_statement (annual, 2023-12-31) — Depreciation Amortization Depletion Income Statement: 990000.00
INFU cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 12508000.00
INFU income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 990000.00
INFU income_statement (annual, 2023-12-31) — Diluted Average Shares: 21646079.00
INFU income_statement (annual, 2023-12-31) — Diluted EPS: 0.04
INFU income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 872000.00
INFU income_statement (annual, 2023-12-31) — EBIT: 4021000.00
INFU income_statement (annual, 2023-12-31) — EBITDA: 16529000.00
INFU cash_flow (annual, 2023-12-31) — End Cash Position: 231000.00
INFU balance_sheet (annual, 2023-12-31) — Financial Assets: 1442000.00
INFU cash_flow (annual, 2023-12-31) — Financing Cash Flow: -4423000.00
INFU cash_flow (annual, 2023-12-31) — Free Cash Flow: 106000.00
INFU cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: -1161000.00
INFU balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: 1088000.00
INFU income_statement (annual, 2023-12-31) — General And Administrative Expense: 45377000.00
INFU balance_sheet (annual, 2023-12-31) — Goodwill: 3710000.00
INFU balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 11156000.00
INFU balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 20430000.00
INFU balance_sheet (annual, 2023-12-31) — Gross PPE: 111143000.00
INFU income_statement (annual, 2023-12-31) — Gross Profit: 63109000.00
INFU cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 213000.00
INFU income_statement (annual, 2023-12-31) — Interest Expense: 2170000.00
INFU income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 2170000.00
INFU cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 2052000.00
INFU balance_sheet (annual, 2023-12-31) — Inventory: 6402000.00
INFU balance_sheet (annual, 2023-12-31) — Invested Capital: 81403000.00
INFU cash_flow (annual, 2023-12-31) — Investing Cash Flow: -6734000.00
INFU cash_flow (annual, 2023-12-31) — Issuance Of Debt: 51552000.00
INFU balance_sheet (annual, 2023-12-31) — Leases: 3570000.00
INFU balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 5799000.00
INFU balance_sheet (annual, 2023-12-31) — Long Term Debt: 29101000.00
INFU balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 34900000.00
INFU cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 51552000.00
INFU cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -55499000.00
INFU balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 6698000.00
INFU cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: 0.00
INFU cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -1311000.00
INFU balance_sheet (annual, 2023-12-31) — Net Debt: 28870000.00
INFU income_statement (annual, 2023-12-31) — Net Income: 872000.00
INFU income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 872000.00
INFU income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 872000.00
INFU income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 872000.00
INFU income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 872000.00
INFU cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 872000.00
INFU income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 872000.00
INFU income_statement (annual, 2023-12-31) — Net Interest Income: -2170000.00
INFU cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -3947000.00
INFU cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -3947000.00
INFU income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -2170000.00
INFU cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -229000.00
INFU balance_sheet (annual, 2023-12-31) — Net PPE: 45952000.00
INFU cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -6734000.00
INFU balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 41146000.00
INFU balance_sheet (annual, 2023-12-31) — Non Current Deferred Assets: 9115000.00
INFU balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 9115000.00
INFU income_statement (annual, 2023-12-31) — Normalized EBITDA: 16529000.00
INFU income_statement (annual, 2023-12-31) — Normalized Income: 872000.00
INFU cash_flow (annual, 2023-12-31) — Operating Cash Flow: 11223000.00
INFU cash_flow (annual, 2023-12-31) — Operating Gains Losses: -1161000.00
INFU income_statement (annual, 2023-12-31) — Operating Income: 4088000.00
INFU income_statement (annual, 2023-12-31) — Operating Revenue: 125785000.00
INFU balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 21196851.00
INFU balance_sheet (annual, 2023-12-31) — Other Current Assets: 4157000.00
INFU balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 7704000.00
INFU balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: 1088000.00
INFU income_statement (annual, 2023-12-31) — Other Gand A: 45377000.00
INFU income_statement (annual, 2023-12-31) — Other Income Expense: -67000.00
INFU balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 7446000.00
INFU cash_flow (annual, 2023-12-31) — Other Non Cash Items: 120000.00
INFU balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 4630000.00
INFU income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: -67000.00
INFU balance_sheet (annual, 2023-12-31) — Other Properties: 100875000.00
INFU balance_sheet (annual, 2023-12-31) — Payables: 8009000.00
INFU balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 8009000.00
INFU balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
INFU income_statement (annual, 2023-12-31) — Pretax Income: 1851000.00
INFU cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 1064000.00
INFU balance_sheet (annual, 2023-12-31) — Properties: 0.00
INFU cash_flow (annual, 2023-12-31) — Provisionand Write Offof Assets: -261000.00
INFU cash_flow (annual, 2023-12-31) — Purchase Of Business: 0.00
INFU cash_flow (annual, 2023-12-31) — Purchase Of PPE: -11117000.00
INFU balance_sheet (annual, 2023-12-31) — Receivables: 19830000.00
INFU income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 51158000.00
INFU income_statement (annual, 2023-12-31) — Reconciled Depreciation: 12508000.00
INFU cash_flow (annual, 2023-12-31) — Repayment Of Debt: -55499000.00
INFU cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -1311000.00
INFU balance_sheet (annual, 2023-12-31) — Retained Earnings: -58625000.00
INFU cash_flow (annual, 2023-12-31) — Sale Of PPE: 4383000.00
INFU income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 12654000.00
INFU income_statement (annual, 2023-12-31) — Selling General And Administration: 58031000.00
INFU balance_sheet (annual, 2023-12-31) — Share Issued: 21196851.00
INFU cash_flow (annual, 2023-12-31) — Stock Based Compensation: 4074000.00
INFU balance_sheet (annual, 2023-12-31) — Stockholders Equity: 52302000.00
INFU balance_sheet (annual, 2023-12-31) — Tangible Book Value: 41146000.00
INFU income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
INFU income_statement (annual, 2023-12-31) — Tax Provision: 979000.00
INFU income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.21
INFU balance_sheet (annual, 2023-12-31) — Total Assets: 102915000.00
INFU balance_sheet (annual, 2023-12-31) — Total Capitalization: 81403000.00
INFU balance_sheet (annual, 2023-12-31) — Total Debt: 34900000.00
INFU balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 52302000.00
INFU income_statement (annual, 2023-12-31) — Total Expenses: 121697000.00
INFU balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 50613000.00
INFU balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 72295000.00
INFU balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 34900000.00
INFU income_statement (annual, 2023-12-31) — Total Operating Income As Reported: 4088000.00
INFU balance_sheet (annual, 2023-12-31) — Working Capital: 14907000.00
INFU income_statement (annual, 2024-12-31) — +Operating Expense: 63512000.00
INFU income_statement (annual, 2024-12-31) — +Total Revenue: 134861000.00
INFU balance_sheet (annual, 2024-12-31) — Accounts Payable: 9848000.00
INFU balance_sheet (annual, 2024-12-31) — Accounts Receivable: 21155000.00
INFU balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -72471000.00
INFU balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 113868000.00
INFU balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -200000.00
INFU balance_sheet (quarterly, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -200000.00
INFU income_statement (annual, 2024-12-31) — Amortization: 991000.00
INFU cash_flow (annual, 2024-12-31) — Amortization Cash Flow: 991000.00
INFU cash_flow (annual, 2024-12-31) — Amortization Of Intangibles: 991000.00
INFU income_statement (annual, 2024-12-31) — Amortization Of Intangibles Income Statement: 991000.00
INFU income_statement (annual, 2024-12-31) — Basic Average Shares: 21271608.00
INFU income_statement (annual, 2024-12-31) — Basic EPS: 0.11
INFU cash_flow (annual, 2024-12-31) — Beginning Cash Position: 231000.00
INFU cash_flow (annual, 2024-12-31) — Capital Expenditure: -17833000.00
INFU balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 4560000.00
INFU balance_sheet (annual, 2024-12-31) — Capital Stock: 2000.00
INFU balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 527000.00
INFU balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 527000.00
INFU cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -6924000.00
INFU cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -13239000.00
INFU cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 20459000.00
INFU cash_flow (annual, 2024-12-31) — Change In Account Payable: -676000.00
INFU cash_flow (annual, 2024-12-31) — Change In Inventory: -126000.00
INFU cash_flow (annual, 2024-12-31) — Change In Other Current Assets: 2155000.00
INFU cash_flow (annual, 2024-12-31) — Change In Payable: -676000.00
INFU cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -676000.00
INFU cash_flow (annual, 2024-12-31) — Change In Receivables: -701000.00
INFU cash_flow (annual, 2024-12-31) — Change In Working Capital: 652000.00
INFU cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -701000.00
INFU cash_flow (annual, 2024-12-31) — Changes In Cash: 296000.00
INFU balance_sheet (annual, 2024-12-31) — Common Stock: 2000.00
INFU balance_sheet (annual, 2024-12-31) — Common Stock Equity: 57529000.00
INFU cash_flow (annual, 2024-12-31) — Common Stock Payments: -1996000.00
INFU income_statement (annual, 2024-12-31) — Cost Of Revenue: 64458000.00
INFU balance_sheet (annual, 2024-12-31) — Current Assets: 32165000.00
INFU balance_sheet (annual, 2024-12-31) — Current Liabilities: 17661000.00
INFU cash_flow (annual, 2024-12-31) — Deferred Income Tax: 1918000.00
INFU cash_flow (annual, 2024-12-31) — Deferred Tax: 1918000.00
INFU cash_flow (annual, 2024-12-31) — Depreciation: 11508000.00
INFU cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 12499000.00
INFU income_statement (annual, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 991000.00
INFU cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 12499000.00
INFU income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 991000.00
INFU income_statement (annual, 2024-12-31) — Diluted Average Shares: 21707151.00
INFU income_statement (annual, 2024-12-31) — Diluted EPS: 0.11
INFU income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 2345000.00
INFU income_statement (annual, 2024-12-31) — EBIT: 6836000.00
INFU income_statement (annual, 2024-12-31) — EBITDA: 19335000.00
INFU cash_flow (annual, 2024-12-31) — End Cash Position: 527000.00
INFU balance_sheet (annual, 2024-12-31) — Financial Assets: 1481000.00
INFU cash_flow (annual, 2024-12-31) — Financing Cash Flow: -6924000.00
INFU cash_flow (annual, 2024-12-31) — Free Cash Flow: 2626000.00
INFU cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: -1326000.00
INFU balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 1119000.00
INFU income_statement (annual, 2024-12-31) — General And Administrative Expense: 51209000.00
INFU balance_sheet (annual, 2024-12-31) — Goodwill: 3710000.00
INFU balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 10166000.00
INFU balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 21355000.00
INFU balance_sheet (quarterly, 2024-12-31) — Gross Accounts Receivable: 21355000.00
INFU balance_sheet (annual, 2024-12-31) — Gross PPE: 121050000.00
INFU income_statement (annual, 2024-12-31) — Gross Profit: 70403000.00
INFU cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 753000.00
INFU income_statement (annual, 2024-12-31) — Interest Expense: 1777000.00
INFU income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 1777000.00
INFU cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 1749000.00
INFU balance_sheet (annual, 2024-12-31) — Inventory: 6528000.00
INFU balance_sheet (annual, 2024-12-31) — Invested Capital: 81393000.00
INFU cash_flow (annual, 2024-12-31) — Investing Cash Flow: -13239000.00
INFU cash_flow (annual, 2024-12-31) — Issuance Of Debt: 50798000.00
INFU balance_sheet (annual, 2024-12-31) — Leases: 4911000.00
INFU balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 4560000.00
INFU balance_sheet (annual, 2024-12-31) — Long Term Debt: 23864000.00
INFU balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 28424000.00
INFU cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 50798000.00
INFU cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -56113000.00
INFU balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 6267000.00
INFU cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 0.00
INFU cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -1996000.00
INFU balance_sheet (annual, 2024-12-31) — Net Debt: 23337000.00
INFU income_statement (annual, 2024-12-31) — Net Income: 2345000.00
INFU income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 2345000.00
INFU income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 2345000.00
INFU income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 2345000.00
INFU income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 2345000.00
INFU cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 2345000.00
INFU income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 2345000.00
INFU income_statement (annual, 2024-12-31) — Net Interest Income: -1777000.00
INFU cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -5315000.00
INFU cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -5315000.00
INFU income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -1777000.00
INFU balance_sheet (annual, 2024-12-31) — Net PPE: 48579000.00
INFU cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -13239000.00
INFU balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 47363000.00
INFU balance_sheet (annual, 2024-12-31) — Non Current Deferred Assets: 7188000.00
INFU balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 7188000.00
INFU income_statement (annual, 2024-12-31) — Normalized EBITDA: 19335000.00
INFU income_statement (annual, 2024-12-31) — Normalized Income: 2345000.00
INFU cash_flow (annual, 2024-12-31) — Operating Cash Flow: 20459000.00
INFU cash_flow (annual, 2024-12-31) — Operating Gains Losses: -1326000.00
INFU income_statement (annual, 2024-12-31) — Operating Income: 6891000.00
INFU income_statement (annual, 2024-12-31) — Operating Revenue: 134861000.00
INFU balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 21272351.00
INFU balance_sheet (annual, 2024-12-31) — Other Current Assets: 3955000.00
INFU balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 7813000.00
INFU balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: 1119000.00
INFU income_statement (annual, 2024-12-31) — Other Gand A: 51209000.00
INFU income_statement (annual, 2024-12-31) — Other Income Expense: -55000.00
INFU balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 6456000.00
INFU cash_flow (annual, 2024-12-31) — Other Non Cash Items: 78000.00
INFU balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 4035000.00
INFU income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: -55000.00
INFU balance_sheet (annual, 2024-12-31) — Other Properties: 109872000.00
INFU balance_sheet (annual, 2024-12-31) — Payables: 9848000.00
INFU balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 9848000.00
INFU balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
INFU income_statement (annual, 2024-12-31) — Pretax Income: 5059000.00
INFU cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 387000.00
INFU balance_sheet (annual, 2024-12-31) — Properties: 0.00
INFU cash_flow (annual, 2024-12-31) — Provisionand Write Offof Assets: -167000.00
INFU cash_flow (annual, 2024-12-31) — Purchase Of Business: 0.00
INFU cash_flow (annual, 2024-12-31) — Purchase Of PPE: -17833000.00
INFU balance_sheet (annual, 2024-12-31) — Receivables: 21155000.00
INFU income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 52950000.00
INFU income_statement (annual, 2024-12-31) — Reconciled Depreciation: 12499000.00
INFU cash_flow (annual, 2024-12-31) — Repayment Of Debt: -56113000.00
INFU cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -1996000.00
INFU balance_sheet (annual, 2024-12-31) — Retained Earnings: -57460000.00
INFU cash_flow (annual, 2024-12-31) — Sale Of PPE: 4594000.00
INFU income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 11312000.00
INFU income_statement (annual, 2024-12-31) — Selling General And Administration: 62521000.00
INFU balance_sheet (annual, 2024-12-31) — Share Issued: 21272351.00
INFU cash_flow (annual, 2024-12-31) — Stock Based Compensation: 4460000.00
INFU balance_sheet (annual, 2024-12-31) — Stockholders Equity: 57529000.00
INFU balance_sheet (annual, 2024-12-31) — Tangible Book Value: 47363000.00
INFU income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
INFU income_statement (annual, 2024-12-31) — Tax Provision: 2714000.00
INFU income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.21
INFU balance_sheet (annual, 2024-12-31) — Total Assets: 103614000.00
INFU balance_sheet (annual, 2024-12-31) — Total Capitalization: 81393000.00
INFU balance_sheet (annual, 2024-12-31) — Total Debt: 28424000.00
INFU balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 57529000.00
INFU income_statement (annual, 2024-12-31) — Total Expenses: 127970000.00
INFU balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 46085000.00
INFU balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 71449000.00
INFU balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 28424000.00
INFU income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 6891000.00
INFU balance_sheet (annual, 2024-12-31) — Working Capital: 14504000.00
INFU income_statement (quarterly, 2025-03-31) — +Operating Expense: 18549000.00
INFU income_statement (quarterly, 2025-03-31) — +Total Revenue: 34716000.00
INFU balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 8367000.00
INFU balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 23892000.00
INFU balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -74582000.00
INFU balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 114898000.00
INFU income_statement (quarterly, 2025-03-31) — Amortization: 248000.00
INFU cash_flow (quarterly, 2025-03-31) — Amortization Cash Flow: 248000.00
INFU cash_flow (quarterly, 2025-03-31) — Amortization Of Intangibles: 248000.00
INFU income_statement (quarterly, 2025-03-31) — Amortization Of Intangibles Income Statement: 248000.00
INFU income_statement (quarterly, 2025-03-31) — Basic Average Shares: 21125019.00
INFU income_statement (quarterly, 2025-03-31) — Basic EPS: -0.01
INFU cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 527000.00
INFU cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -3415000.00
INFU balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 4458000.00
INFU balance_sheet (quarterly, 2025-03-31) — Capital Stock: 2000.00
INFU balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 1506000.00
INFU balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 1506000.00
INFU cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 1860000.00
INFU cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -2661000.00
INFU cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 1780000.00
INFU cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -1577000.00
INFU cash_flow (quarterly, 2025-03-31) — Change In Inventory: 433000.00
INFU cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: 855000.00
INFU cash_flow (quarterly, 2025-03-31) — Change In Payable: -1577000.00
INFU cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -1577000.00
INFU cash_flow (quarterly, 2025-03-31) — Change In Receivables: -2095000.00
INFU cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -2384000.00
INFU cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -2095000.00
INFU cash_flow (quarterly, 2025-03-31) — Changes In Cash: 979000.00
INFU balance_sheet (quarterly, 2025-03-31) — Common Stock: 2000.00
INFU balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 55148000.00
INFU cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -3123000.00
INFU income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 15549000.00
INFU balance_sheet (quarterly, 2025-03-31) — Current Assets: 35322000.00
INFU balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 15969000.00
INFU cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: 520000.00
INFU cash_flow (quarterly, 2025-03-31) — Deferred Tax: 520000.00
INFU cash_flow (quarterly, 2025-03-31) — Depreciation: 3072000.00
INFU cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 3320000.00
INFU income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 248000.00
INFU cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 3320000.00
INFU income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 248000.00
INFU income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 21125019.00
INFU income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.01
INFU income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -267000.00
INFU income_statement (quarterly, 2025-03-31) — EBIT: 589000.00
INFU income_statement (quarterly, 2025-03-31) — EBITDA: 3909000.00
INFU cash_flow (quarterly, 2025-03-31) — End Cash Position: 1506000.00
INFU balance_sheet (quarterly, 2025-03-31) — Financial Assets: 1152000.00
INFU cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 1860000.00
INFU cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -1635000.00
INFU cash_flow (quarterly, 2025-03-31) — Gain Loss On Sale Of PPE: -581000.00
INFU balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 870000.00
INFU income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 15316000.00
INFU balance_sheet (quarterly, 2025-03-31) — Goodwill: 3710000.00
INFU balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 9918000.00
INFU balance_sheet (quarterly, 2025-03-31) — Gross PPE: 122363000.00
INFU income_statement (quarterly, 2025-03-31) — Gross Profit: 19167000.00
INFU income_statement (quarterly, 2025-03-31) — Interest Expense: 336000.00
INFU income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 336000.00
INFU balance_sheet (quarterly, 2025-03-31) — Inventory: 6095000.00
INFU balance_sheet (quarterly, 2025-03-31) — Invested Capital: 83855000.00
INFU cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -2661000.00
INFU cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 19231000.00
INFU balance_sheet (quarterly, 2025-03-31) — Leases: 4963000.00
INFU balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 4458000.00
INFU balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 28707000.00
INFU balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 33165000.00
INFU cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 19231000.00
INFU cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -14407000.00
INFU balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 6404000.00
INFU cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -3123000.00
INFU balance_sheet (quarterly, 2025-03-31) — Net Debt: 27201000.00